Navigation Links
Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-101 Repositioned Drug for Multiple Sclerosis
Date:4/2/2009

ally relevant unmet medical needs. Biovista's proprietary repositioning technology allows the company's experts to perform mechanism-of-action based analyses and systematically assess clinical outcomes in any therapeutic area of interest, at relatively low cost and very short time spans. The company is presently using this platform to develop its own pipeline of repositioned drugs in areas such as CNS, cardiovascular disease, oncology and auto-immune diseases and is expecting to make further announcements in Q3 '09.

    For more information, please contact:
    Dr. Aris Persidis
    Biovista, Inc.
    +1-434-242-6514
    arisp@biovista.com

    For a non-confidential information pack on BVA-101 contact Biovista at
    info@biovista.com.


'/>"/>
SOURCE Biovista Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015 Emerson Ecologics is ... The Business of Better Medicine . The conference will ... to develop a thriving and fulfilling practice. ... La Costa Resort and Spa, the conference will be ... expect to accomplish key projects and leave with an ...
(Date:4/1/2015)... 2015  VLP Therapeutics, LLC. ("VLP"), a ... and development of therapeutic and preventative vaccines and next ... vaccine technology, today announced that it has entered into a ... Nagasaki University in ... and development of dengue vaccine candidates. ...
(Date:4/1/2015)... Goldman Small Cap Research, a stock market ... sectors, announced today that it has issued a new ... publicly traded clinical stage biotechnology company focused on developing ... the sponsored research article, along with disclosures and disclaimers, ... www.GoldmanResearch.com .  In the article ...
(Date:4/1/2015)... -- EMD Serono, the U.S. biopharmaceuticals subsidiary of Merck KGaA, ... appointment of Frederick E. Munschauer to Vice ... capacity, he will lead the medical affairs activities for ... Rebif ® (interferon beta-1a) as well as the ... Munschauer joins EMD Serono from Biogen, bringing more than ...
Breaking Biology Technology:Emerson Ecologics Announces First Annual Conference for Integrative Healthcare Practitioners 2Emerson Ecologics Announces First Annual Conference for Integrative Healthcare Practitioners 3VLP Therapeutics Enters Collaboration with Institute of Tropical Medicine, Nagasaki University 2VLP Therapeutics Enters Collaboration with Institute of Tropical Medicine, Nagasaki University 3Flurry of Biotech Mergers and Acquisitions Bodes Well for PharmaCyte Biotech 2Flurry of Biotech Mergers and Acquisitions Bodes Well for PharmaCyte Biotech 3Flurry of Biotech Mergers and Acquisitions Bodes Well for PharmaCyte Biotech 4EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 2EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 3EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 4EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 5
... AMSTERDAM, October 13 Amsterdam ... human gene therapy,announced today that the European Medicines Agency ... AMT-080 for the treatment of,Duchenne muscular dystrophy. , ... dystrophy (DMD) entitles,AMT to ten year market exclusivity in ...
... Chopra ... Stephanie Simonton, have created "Return to Wholeness: A Mind-body Approach to Healing Cancer" ... to strengthen their immune system, reduce the side effects of treatment, and awaken the ... ...
... BOZEN, Italy, October 12 ... installation of the first,five i.v.STATION post-prototype robots in the ... to November timeframe this year; concurrently,Health Robotics also made ... Science Park 3L 3T Innovation Award, which is given ...
Cached Biology Technology:AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy 2AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy 3Healing Cancer Through Mind-Body Medicine: The Chopra Center Releases Pioneering DVD for Every Stage of Treatment 2Healing Cancer Through Mind-Body Medicine: The Chopra Center Releases Pioneering DVD for Every Stage of Treatment 3Health Robotics Announces First Five i.v.STATION(TM) Robot Shipments and Receipt of 3L/3T Innovation Award 2Health Robotics Announces First Five i.v.STATION(TM) Robot Shipments and Receipt of 3L/3T Innovation Award 3
(Date:4/2/2015)... According to preliminary estimates Fingerprint ... higher than 125 MSEK. This exceeds the guidance provided ... revenues for Q1 2015 would be in line with ... 2014. The operating result for the first quarter is ... report will as previously communicated be published on May ...
(Date:4/2/2015)... , April 2, 2015 ... touch fingerprint sensor FPC1025 from the distributor World Peace ... commence during Q2 2015 although the major part of ... sensors will be used by smartphone manufacturers in ... MSEK is included in the communicated revenue guidance of ...
(Date:4/1/2015)... Conn. , Apr. 1, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... of Wocket smart wallets is underway to early access ... access group includes usage at retail outlets including Walmart, ... Pharmacy. Users report Wocket was accepted at all outlets ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... CAMBRIDGE, MA -- Earthworms creep along the ground by ... their bodies, inching forward with each wave of contractions. ... peristalsis, to get around, and our own gastrointestinal tracts ... esophagus to push food to the stomach. Now ...
... Rochelle, NY, August 9, 2012Despite criticism from Congressional Republicans ... Rim of the Pacific (RIMPAC) 2012 international maritime exercises, ... biofuels blend. The Navy contends that renewable energy resources ... in enhancing national security and energy independence. Tom Hicks, ...
... trees are one of the biggest contributors to air ... chemicals many of which are produced by human ... air. New research from a team led by Carnegie ... formed from pine tree emissions are much more chemically ...
Cached Biology News:Soft autonomous robot inches along like an earthworm 2Soft autonomous robot inches along like an earthworm 3US Navy defends renewable fuels strategy in Industrial Biotechnology Journal 2Carnegie Mellon study shows skin-aging radicals age naturally formed particles in the air 2Carnegie Mellon study shows skin-aging radicals age naturally formed particles in the air 3
Useful for determination of glucose and ATP. Packaging: Package sizes are based on hexokinase units. Preparation Unit Definition: One unit will phosphorylate 1.0 mol of D -glucose per min at pH ...
... form: Lyophilized powder containing ... Unit Definition: One unit ... 2-phosphoglycerate to phospho(enol)pyruvate per ... 25 C. Chem comp: ...
SCCRO (S-17)...
Packaging: 6 bottles for 1 l ready-to-use-solution ID clarifier: ready-to-use solution ...
Biology Products: